/Cardinal%20Health%2C%20Inc_%20logo%20on%20building%20by-%20JHVEPhoto%20via%20Shutterstock.jpg)
Valued at around $24 billion by a market cap, Cardinal Health, Inc. (CAH) is a healthcare services and products company providing pharmaceutical and medical solutions globally. The Dublin, Ohio-based company is expected to unveil its fiscal Q4 earnings results before the market opens on Wednesday, Aug. 14.
Prior to the event, analysts anticipated the prescription drug distributor to report a profit of $1.72 per share, up around 11% from $1.55 per share in the same quarter last year. The company has consistently surpassed Wall Street's earnings projections over the last four quarters. CAH reported an EPS of $2.08 in Q3 2024, exceeding the consensus estimate by a 6.7% margin.